FDA News

FDA approves Herzuma, biosimilar to Herceptin, for breast cancer subset

December 14, 2018
The FDA today approved trastuzumab-pkrb for the treatment of patients with HER2-positive breast cancer, the agency announced in a press release…

Meeting NewsPerspective

Chemotherapy, radiation may increase risk for subsequent acute lymphoblastic leukemia

December 12, 2018
SAN DIEGO — Prior cancer treatment with chemotherapy, radiation or both for was associated with an increased risk for subsequent acute…

In the Journals Plus

Growing prevalence of excess body weight increasing global cancer burden

December 12, 2018
The increasing prevalence of excess body weight, which was responsible for approximately 3.9% of all cancers worldwide in 2012, is driven by multiple…

In the Journals

Breast cancer risk after childbirth may persist more than 20 years

December 10, 2018
The increased risk for breast cancer after giving birth can last for around 24 years, according to findings published in Annals of Internal

Meeting News

Oxybutynin shows promise for managing hot flashes among breast cancer survivors

December 7, 2018
SAN ANTONIO — Oxybutynin significantly reduced the frequency and severity of hot flashes among breast cancer survivors, according to results of…

Meeting News

Addition of pembrolizumab to chemotherapy demonstrates promise in triple-negative breast cancer

December 7, 2018
SAN ANTONIO — The addition of pembrolizumab to neoadjuvant chemotherapy demonstrated promising antitumor activity and exhibited a manageable…

Meeting NewsPerspective

Lifestyle intervention improves outcomes for some breast cancer survivors

December 7, 2018
SAN ANTONIO — Completion of a lifestyle intervention program that focused on healthy habits appeared associated with weight loss and increased…

Meeting NewsPerspective

Exercise during adjuvant breast cancer treatment may improve cardiovascular function

December 7, 2018
SAN ANTONIO — A supervised 12-month exercise program improved cardiovascular function among women undergoing adjuvant breast cancer treatment…

Meeting NewsPerspective

Surgery choice affects quality of life among younger patients with breast cancer

December 7, 2018
SAN ANTONIO — Local therapy decisions appeared to significantly affect quality of life among young breast cancer survivors, according to study…

Meeting NewsPerspective

Accelerated partial breast irradiation noninferior to whole breast irradiation for invasive breast cancer

December 7, 2018
SAN ANTONIO — Accelerated partial breast irradiation appeared noninferior to whole breast irradiation for preventing local recurrence among…

Meeting NewsPerspective

Axillary radiotherapy, lymph node surgery for early breast cancer confer comparable outcomes

December 6, 2018
SAN ANTONIO — Axillary radiotherapy and axillary lymph node dissection appeared associated with excellent and comparable 10-year recurrence and…

Meeting NewsPerspective

Low-dose tamoxifen reduces recurrence of breast intraepithelial neoplasia

December 6, 2018
SAN ANTONIO — Use of low-dose tamoxifen reduced risk for recurrence among a cohort of women who underwent treatment for breast intraepithelial…

Meeting News

One year of trastuzumab remains standard for HER2-positive early-stage breast cancer

December 6, 2018
SAN ANTONIO — One year of adjuvant trastazumab should remain the standard of care for patients with HER2-positive early-stage breast cancer…

Meeting News

Addition of alpelisib to fulvestrant significantly prolongs PFS in advanced PIK3CA-mutant breast cancer

December 6, 2018
SAN ANTONIO — The addition of alpelisib to fulvestrant nearly doubled PFS among patients with PIK3CA-mutant, hormone receptor-positive…

Meeting NewsPerspective

Trial reveals ‘very small’ differences between accelerated partial breast irradiation, whole breast irradiation for early-stage cancer

December 6, 2018
SAN ANTONIO — Accelerated partial breast irradiation appears close but not equivalent to whole breast irradiation for control of ipsilateral…

Meeting News

Some elderly patients with breast cancer less likely to receive adjuvant chemotherapy despite OS benefit

December 5, 2018
SAN ANTONIO — Several factors influenced receipt of adjuvant chemotherapy among a cohort of elderly women with breast cancer, according to…

Meeting NewsPerspective

Delayed initiation of adjuvant chemotherapy linked to poorer outcomes in triple-negative breast cancer

December 5, 2018
SAN ANTONIO — Longer delays to initiation of adjuvant chemotherapy appeared associated with poorer outcomes among patients with triple-negative…

Meeting NewsPerspective

Researchers identify gene alterations linked to certain metastatic breast cancers

December 5, 2018
SAN ANTONIO — Ten driver gene alterations appeared more common among a cohort of patients with metastatic hormone receptor-positive…

Meeting NewsPerspective

Patients with breast cancer who respond to neoadjuvant treatment may not need adjuvant chemotherapy

December 5, 2018
SAN ANTONIO — Patients with breast cancer who achieved pathologic complete response to neoadjuvant chemotherapy attained similar survival…

Meeting NewsPerspective

Adjuvant capecitabine fails to extend survival in early-stage triple-negative breast cancer

December 5, 2018
SAN ANTONIO — Adjuvant capecitabine did not prolong DFS or OS among women with early-stage triple-negative breast cancer who underwent surgery…